In September 2010, the U.S. Food and Drug Administration (FDA) announced that it would be severely restricting the use of rosiglitazone due to the risk of "cardiovascular events" such as heart attacks and strokes. Only individuals who cannot control their diabetes on other medications (or those who are already taking the medication and doing well) will be able to take rosiglitazone.
What Is Rosiglitazone and Metformin?
Who Makes Rosiglitazone and Metformin?
Rosiglitazone and metformin is manufactured by GlaxoSmithKline.